首页> 外国专利> Lysine-specific Porphyromonas gingivalis proteinase

Lysine-specific Porphyromonas gingivalis proteinase

机译:赖氨酸特异性牙龈卟啉单胞菌蛋白酶

摘要

Provide herein is a substantially pure Lys-gingipain complex preparation, Lys-gingipain being characterized as having an apparent molecular mass of 105 kDa as estimated by sodium dodecyl sulfate polyacrylamide gel electrophoresis, where sample is prepared without boiling, said Lys-gingipain having amidolytic and proteolytic activity for cleavage after lysine residues and having no amidolytic and/or proteolytic activity for cleavage after arginine residues, wherein the amidolytic and/or proteolytic activity is inhibited by TLCK, cysteine protease group-specific inhibitors including iodoacetamide and iodoacetic acid, wherein the amidolytic and/or proteolytic activity of said Lys- gingipain is not sensitive to inhibition by leupeptin, antipain, trans- epoxysuccinyl-L-leucylamido-(4-guanidino)butane, serine protease group- specific inhibitors including diisopropylfluorophosphate and phenylmethyl sulfonylfluoride, and antibodies specific for the Lys-gingipain protein complex and its catalytic component, methods for preparation. As specifically exemplified, a Lys-gingipain protein complex is purified from Porphyromonas gingivalis H66, and the 60 kDa catalytic component of the Lys-gingipain protein complex has an amino acid sequence as given in SEQ ID NO:14 from amino acid 1 through amino acid 509. Also provided are nucleic acid sequences encoding this catalytic protein. The nucleotide coding sequence of the 60 kDa catalytic component of the Lys-gingipain protein complex is given in SEQ ID NO:13, from nucleotide 1336 through nucleotide 2863. The Lys-gingipain complex also comprises a hemagglutinin component identified by an N-terminal amino acid sequence as given in SEQ ID NO:14, amino acids 510-714.
机译:本文提供了基本上纯的Lys-gingipain复合物制剂,Lys-gingipain的特征在于通过十二烷基硫酸钠聚丙烯酰胺凝胶电泳估计具有105kDa的表观分子量,其中样品未沸腾地制备,所述Lys-gingipain具有酰胺化和赖氨酸残基后的裂解具有蛋白水解活性,而精氨酸残基后的裂解没有酰胺水解和/或蛋白水解活性,其中TLCK,半胱氨酸蛋白酶基特异性抑制剂(包括碘乙酰胺和碘乙酸)抑制酰胺化和/或蛋白水解活性,其中酰胺水解Lys-gingipain的蛋白水解和/或蛋白水解活性对亮肽素,抗痛药,反-环氧琥珀酰-L-亮氨酰胺基-(4-胍基)丁烷,丝氨酸蛋白酶基特异的抑制剂(包括二异丙基氟磷酸酯和苯基甲基磺酰氟)的抑制作用和特异性抗体不敏感Lys-gingipain蛋白复合物及其催化剂ic成分,制备方法。如具体示例,从齿龈卟啉单胞菌H66中纯化Lys-gingipain蛋白复合物,并且Lys-gingipain蛋白复合物的60kDa催化组分具有如SEQ ID NO:14中给出的从氨基酸1至氨基酸的氨基酸序列。 509.还提供了编码该催化蛋白的核酸序列。 Lys-gingipain蛋白复合物的60 kDa催化成分的核苷酸编码序列在SEQ ID NO:13中给出,从核苷酸1336到核苷酸2863。Lys-gingipain复合物还包含由N端氨基识别的血凝素成分SEQ ID NO:14给出的氨基酸序列,氨基酸510-714。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号